Nuevos anticoagulantes orales
Thromboembolic disease (TED) is the leading cause of morbidity and mortality worldwide. The hallmark of oral long-term anticoagulant therapy has been the use of vitamin K antagonists, whose anticoagulant effect is exerted inhibiting vitamin K epoxide reductase. Warfarin and acenocoumarol are the mos...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Language: | Spanish / Castilian |
| Published: |
Sociedad Médica de Santiago
2011
|
| Subjects: | |
| Online Access: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872011001000016 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|